Search bioRxiv⌕ Search

bioRxiv · 10.64898/2026.03.07.710286

Computed atlas of the human GPCR-G protein signaling complexes

Abstract

Experimental mapping of G protein-coupled receptors (GPCR)-G protein signaling coupling has illuminated hundreds of receptors, yet the coupling specificity of a large fraction of this large receptor family remains unknown, thereby preventing the development of new GPCR-targeting therapies. Here, we used AlphaFold3 (AF3) to predict the 3D structures of the human GPCRome in complex with heterotrimeric G proteins. We used experimental GPCR-G protein binding data to show that AF3 predictions significantly discriminate between positive and negative binders, and used 3D structural features to train a machine learning (ML) algorithm to predict coupling potency. Interpretation of the ML model helped discriminate universal features governing the strength of G protein coupling from those determining binding specificity. We computationally illuminated the coupling preferences of 180 non-olfactory GPCRs (non-OR) with previously unreported transduction mechanisms and experimentally validate the predicted couplings for multiple previously uncharacterized GPCRs, including QRFPR, GPR50, GPR37, GPR37L1 and GPRC5A. Our predictions established that Gi/o is the most prevalent coupling among non-OR GPCRs, which is often co-occurring with Gq/11 and, to a lesser extent, G12/13 signaling. Gs coupling is less common and restricted to specific clusters within the non-OR GPCRome phylogeny, likely due to stricter structural requirements for its binding. We also computed G protein complexes for over 400 ORs, establishing Gs as the most prevalent coupling. ORs are predicted to bind to Gs with a simpler interface compared to non-ORs, ultimately leading to energetically less stable complexes. Additionally, we predict recurrent bindings to Gq/11 and Gi/o proteins for ORs, suggesting potentially novel ORs signaling mechanisms. We exploited the GPCRome coupling atlas to interpret healthy and cancer expression data, revealing the coupling of most GPCR-G protein co-expressed pairs. This analysis highlights a richer coupling repertoire in healthy tissues compared to cancer, likely reflecting the high signaling requirements of specialized normal cell functions, which are lost in most cancer cells due to their de-differentiated state or under cancer selection processes. In summary, this study provides the first computational 3D atlas of the human GPCR-G protein transductome, thereby illuminating the signaling mechanisms of neglected GPCR classes and providing the basis for interpreting omics datasets from a myriad of pathological conditions, thus enabling the development of novel precision therapeutics.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Miglionico, P., Matic, M., Franchini, L., Arai, H., Nemati Fard, L. A., Arora, C., Gherghinescu, M., DeOliveira Rosa, N., Ryoji, K., Gutkind, J. S., Orlandi, C., Inoue, A., Raimondi, F.. 2026-03-10. Computed atlas of the human GPCR-G protein signaling complexes. https://doi.org/10.64898/2026.03.07.710286

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Targeted finetuning enables co-folding models to learn ligand-induced protein conformational states

Advances in protein structure prediction have enabled all-atom protein-ligand co-folding models that predict bound conformations directly from sequence and small-molecule structure. However, these models often fail to generalize to novel binding sites or alternative protein conformational states, limiting their utility for chemical biology and drug discovery. Here we show this limitation reflects training data bias rather than architectural constraints and can be overcome through targeted finetuning. Using ten previously unseen X-ray structures of Werner (WRN) helicase from a drug discovery program, we finetune Boltz-1 to learn both an allosteric binding site and a large conformational change locking the enzyme in an inactive state, while preserving accuracy on the ATP-bound state. The finetuned model generalizes to different chemical series and transfers the conformational logic across RecQ-family helicases in a binding-site sequence-dependent manner. This approach provides a blueprint for adapting foundation models as new structural and mechanistic data emerge, enabling co-folding networks to capture ligand-induced conformational switches and binding poses absent from their training data but central to biological regulation and therapeutic intervention.

bioinformatics↗

Benchmarking single-cell foundation models for aging biology

Single cell foundation models (scFMs) provide representations of cellular states, but their utility across biological questions in aging research remains unclear. We established a benchmark of cellular representations for aging research, evaluating ten general-purpose scFMs, three aging-specific models and conventional methods across five biological questions using more than 2.5 million single cell transcriptomes. Using frozen pretrained representations, Geneformer performed best among scFMs for chronological age prediction and age pseudotime concordance, although 2,000 highly variable genes achieved higher mean performance. Several scFMs captured positive molecular age shifts across three disease contexts, consistent with reported aging-associated changes. SCimilarity performed well for rare cellular state identification across out-of-distribution datasets, exceeding aging specific models and conventional baselines. At the gene level, scGPT showed the highest recovery of reference TF target interactions, including aging-related regulatory hubs. Overall, scFMs supported diverse aging analyses, but performance depended on the biological question, highlighting their utility for rare cellular state identification and regulatory analysis.

bioinformatics↗

CryoMV: Structure-Prior-Guided Modeling and Real-Particle Validation of Continuous Conformational Transitions in Cryo-EM

Continuous protein conformations are essential for understanding fundamental biological processes and supporting drug discovery. Although cryo-EM can resolve individual states at high resolution, recovering continuous heterogeneity from 2D particle images remains challenging. High noise, motion blur, and limited structural priors make it difficult to accurately generate and validate high-resolution continuous conformations using raw particle data. Here, we introduce cryoMV, a framework that integrates structure-prior-guided modeling with real-particle validation for continuous conformational transitions. CryoMV uses reference density maps to establish structural anchors and motion priors, models candidate transition paths between selected conformations, and transfers the learned representation to raw 2D cryo-EM particle images. Each candidate conformation is subsequently evaluated using the estimated particle poses and contrast transfer functions. Supported conformations are reconstructed through raw particle back-projection and assessed using canonical half-maps and Fourier shell correlation. On EMPIAR-10516 and EMPIAR-10345, cryoMV achieves excellent performance in terms of robustness, verifiability, and reconstruction resolution. By incorporating structure-prior modeling and evidence from the raw particles, cryoMV offers an explicit mechanism for assessing whether generated conformations are supported by experimental data and provides a practical approach to reducing model-induced artifacts in continuous cryo-EM heterogeneity analysis.

bioinformatics↗